Researchers at the Walter and Eliza Hall Institute of Medical Research (WEHI) and the University of Melbourne are working on a project they hope will result in clear experimental guidelines and methods for mathematical analysis for microarrays. [ + ]

Genetically modified oilseed poppies will be field-tested in Tasmania after receiving approval last week from both the Office of the Gene Technology Regulator (OGTR) and the Tasmanian State Government's Department of Primary Industries, Water and the Environment (DIPWE). [ + ]

A new economic model indicates Australia won't reap an export bonanza by adopting genetically modified (GM) crops, but could see its market share stagnate or decline if it rejects or over-regulates GM crops and foods. [ + ]

Gene silencing company Benitec is treating its de-listing by the Australian Stock Exchange as an administrative hiccup but the incident comes at an awkward time for the young biotech. [ + ]

Australian National University researchers have been awarded a $9 million grant by the US Government to establish a unique library of mice in order to identify genes which regulate immunity and tolerance of disease.

'Smart yoghurts' that improve people's immunity and potentially fight cancer may soon hit the supermarkets shelves following a research breakthrough at the University of Western Sydney.

Perth entrepreneur Farooq Khan has junked his plan to pursue a scrip-based hostile takeover of Biota Holdings Ltd. [ + ]

Ophthalmic laser manufacturer Ellex Medical was battered this week after announcing a downturn in revenues caused by lower than expected sales, as well as the unanticipated resignation of managing director Peter Rowland due to differences with the board over the direction of the company. [ + ]

A new approach to treating pain has been licensed to British company RiboTargets by Monash University in a deal brokered by Victorian technology commercialisation company Biocomm. [ + ]

Two Melbourne companies, Autogen and Antisense Therapeutics, have launched fully underwritten share placements to raise more than $10 million between them in capital. [ + ]

The University of Adelaide has opened its newest laboratory - in China.

IDG Communications, publisher of Australian Biotechnology News, this week acquired two titles -- Today's Life Science and Lab News -- from Vertical Markets. [ + ]

Queensland biotech Progen Industries and business development vice president Dr Peter Devine have parted company. [ + ]

Pharmaceutical giant Abbott Laboratories has signed an agreement with UK-based Domantis that gives it non-exclusive access to Domantis' single-domain designer technology for new 'lite' antibody therapeutics. [ + ]

A method of monitoring blood flow in human body tissue without touching the skin has been developed by researchers at Loughborough University, in the English Midlands.